DossierENTITY

Phase 3 maintenance study

Coverage of Phase 3 maintenance study in the Nexus archive.

Earliest in view: Jun 30 · 13:30 UTCMost recent: Jun 30 · 13:30 UTC

Co-mentioned in this coverage

Recent coverage

HEALTHJun 30 · 13:30 UTCQUARTZ
Abivax stock surges as new trial data ease cancer fears over bowel disease drug
Abivax stock surged following new Phase 3 trial data indicating malignancy rates among ulcerative colitis patients align with typical expectations, easing concerns about cancer risks linked to the bowel disease drug.